WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

Hier ist die WuXi nicht direkt betroffen, aber durch die Partnerschaft an der Einreichung mit beteiligt. Anfang 2019 hatten WuXi Bio und CANbridge ihre Partnerschaft erweitert: die Rechte für die Therapien bleiben bei CANbridge, WuXi erhält dafür bspw. Voraus- und Meilensteinzahlungen. https://www.businesswire.com/news/home/20210802005178/en/CANbridge-Pharmaceuticals-CAN103-Investigational-New-Drug-Application-Accepted-by-China%E2%80%99s-National-Medical-Products-Administration CANbridge Pharmaceuticals Inc., ..., announced that the Investigational New Drug (IND) application for CAN103 has been accepted by the Chinese National Medical Products Administration (NMPA). CAN103 is an enzyme replacement therapy (ERT) being developed by CANbridge as part of its rare disease partnership with WuXi Biologics (2269 HK) for the long-term treatment of adults and children with Gaucher disease, Types I and III. ...

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate https://www.prnewswire.com/news-releases/wuxi-biologics-biosafety-testing-facility-received-second-ema-gmp-certificate-301345995.html

WuXi Biologics (02269 HK) plans to hold board meeting on August 23 to review interim results https://m.jrj.com.cn/madapter/hk/2021/07/29200733170972.shtml WuXi Biologics (02269 HK) announced that the company would like to hold a board meeting on August 23, 2021 (Monday), in order to (among other things) consider and approve the group's deadline to June 2021 Interim results and publication for the six months ended on the 30th.

How should investors choose between the high valuation of WuXi Biologics vs. the low valuation of Tigermed and Kanglong Chemical? https://hk.investing.com/news/stock-market-news/article-179297

10 € finde ich schon sportlich, aber bekanntlich ist ja nichts unmöglich 🙃

Wird wohl nichts mit den 10 € 😂 aber lass das Körbchen mal dort stehen. Selten solch eine Gegenbewegung gesehen. Chapeau!

JPM: Focus on High-Quality Pharmas Post-correction, Incl. WUXI BIO, WUXI APPTEC http://www.aastocks.com/en/stocks/analysis/stock-aafn-con/02269/NOW.1115772/hk-stock-news

Bei 10,00 Euro ist mein Körbchen aufgestellt. Mal gucken ob noch ein paar eingesammelt werden

Ja, ist momentan nicht so einfach. Heute gibt es eine gewisse Gegenbewegung, aber ob sie bei der Politik und Marktlage die Tage/ Wochen anhalten wird, bleibt natürlich fraglich.

Hier geht es jetzt auch richtig in den Keller.

Diese Regierung sorgt noch dafür, dass ich graue Haare bekomme...🤦‍♂️

M Stanley's Ratings, TPs on CN Pharma, Medical-related Shrs; 4 Top-pick List (Table) http://www.aastocks.com/en/stocks/analysis/stock-aafn-con/02359/NOW.1115314/hk-stock-news ... Morgan Stanley's four pharma top-picks are as follows: ... WUXI BIO (02269 HK) | Overweight｜164

WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility https://finance.yahoo.com/news/wuxi-biologics-received-commercial-manufacturing-100000327.html • First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system • Only 12 months from facility qualification to licensure demonstrating global adoption of "WuXi Biologics Speed" ...

Hong Kong stocks move | Pharmaceutical stocks fell more than 4% in early trading, WuXi Biologics (02269) fell more than 8% at one point https://finance.sina.cn/hkstock/ggyw/2021-07-26/detail-ikqciyzk7668060.d.html?from=wap

http://www.aastocks.com/en/stocks/news/aafn-con/rum.210721_103236/latest-news

WuXi Biologics to cash in $10b https://www.thestandard.com.hk/section-news/section/2/232309/WuXi-Biologics-to-cash-in-$10b WuXi Biologics, the major shareholder of Wuxi Biologics Cayman (2269) plans to offload 78 million shares to cash in HK$10 billion. It is seeking to raise up to US$1.3 billion (HK$10.07 billion) by placing the shares at a range between HK$128 and HK$130. This represents a discount of between 5.8 percent and 7.3 percent against yesterday's closing price of HK$138.69 million. Morgan Stanley is the sole placement agent. ...